Table 4.
The correlation between risk groups and clinical features.
| Low risk | High risk | ||||
|---|---|---|---|---|---|
| Variables | N | % | N | % | P |
| Age | P = 0.773 | ||||
| ≤ 69 | 131 | 54.36 | 42 | 52.50 | |
| >69 | 110 | 45.64 | 38 | 47.50 | |
| Sex | P = 0.496 | ||||
| Male | 116 | 48.13 | 35 | 43.75 | |
| Female | 125 | 51.87 | 45 | 56.25 | |
| T stage | P = 0.595 | ||||
| T1 | 6 | 2.49 | 1 | 1.25 | |
| T2 | 47 | 19.50 | 11 | 13.75 | |
| T3 | 163 | 67.63 | 59 | 73.75 | |
| T4 | 25 | 10.37 | 9 | 11.25 | |
| N stage | P = 0.850 | ||||
| N0 | 143 | 59.34 | 50 | 62.50 | |
| N1 | 56 | 23.24 | 18 | 22.50 | |
| N2 | 42 | 17.43 | 12 | 15.00 | |
| TNM stage | P = 0.253 | ||||
| I | 48 | 19.92 | 11 | 13.75 | |
| II | 92 | 38.17 | 37 | 46.25 | |
| III | 70 | 29.05 | 18 | 22.50 | |
| IV | 31 | 12.86 | 14 | 17.50 | |